NIFTY 50▲24,211.35
216.00 (0.90%)
SENSEX▲79,477.11
694.87 (0.88%)
NIFTY BANK▲52,246.00
1030.75 (2.01%)
TATA MOTORS▲836.70
12.60 (1.53%)
SUZLON ENERGY▲67.41
1.09 (1.64%)
TATA STEEL▲152.15
5.20 (3.54%)
INDIAN RAILWAY FINANCE CORP▼151.49
-1.75 (-1.14%)
TATA POWER▲433.80
4.75 (1.11%)
RAIL VIKAS NIGAM▲450.55
4.35 (0.97%)
RELIANCE INDUSTRIES1,302.15
0.00 (0.00%)
VODAFONE IDEA▲8.14
0.26 (3.30%)
ZOMATO▼242.91
-2.17 (-0.89%)
RELIANCE POWER▼41.62
-0.41 (-0.98%)
INDIAN RENEWABLE ENERGY▼204.86
-0.52 (-0.25%)
ADANI POWER▲605.40
20.40 (3.49%)
YES BANK▲20.65
0.32 (1.57%)
STATE BANK OF INDIA▲849.30
19.45 (2.34%)
NHPC▼80.45
-2.85 (-3.42%)
HDFC BANK▲1,758.30
44.20 (2.58%)
OLA ELECTRIC MOBILITY LTD▼74.25
-6.59 (-8.15%)
JIO FIN SERVICES LTD▲321.80
1.95 (0.61%)
INDIAN OIL CORP▲140.73
1.80 (1.30%)
BHARAT ELECTRONICS▲286.65
2.50 (0.88%)
GTL INFRA▲2.21
0.10 (4.74%)
MRF▼1,19,627.95
-1248.80 (-1.03%)
ADANI PORT & SEZ▼1,327.00
-22.25 (-1.65%)
JAIPRAKASH POWER VENTURES▲18.00
0.12 (0.67%)
ITC▼479.35
-5.25 (-1.08%)
Aarti Drugs Share Price
AARTIDRUGS
₹487.25+₹3.35 (0.69%) TodayLast updated on 05 Nov, 2024 | 15:08 IST
Aarti Drugs Share Price Chart
Please wait...
About Aarti Drugs
Aarti Drugs Financials
Market cap ₹4,417 Crs | Open ₹484.05 | Close ₹483.90 |
Circuit range ₹580.65 - ₹387.15 | Day range ₹480.80 - ₹491.55 | Year range ₹431.05 - ₹635.00 |
Volume 87,088 | Avg. traded ₹486.07 | Revenue (12m) ₹2,380 Crs |
Aarti DrugsAarti Drugs Limited is an India-based company, which is engaged in manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates through pharmaceuticals segment. The Company's APIs products include iprofloxacin hydrochloride, metronidazole, metformin HCL, ketoconazole, ofloxacin, and others. Its specialty chemicals includes benzene sulphonyl chloride, methyl nicotinate, among others. Its pharma intermediates products include tinidazole, celecoxib, ciprofloxacin, clopidogrel, diclofenac, ketoconazole, raloxifene and zolpidem. Its products under development include alpha lipoic acid, itraconazole, ticagrelor, and sitagliptin. The Company's subsidiaries include Pinnacle Life Science Private Limited, Aarti Speciality Chemicals Limited, and Pinnacle Chile SPA.
Aarti Drugs Key indicators
52 week high ₹635.00 | 52 week low ₹431.05 | P/E ratio 29.12 |
P/B ratio 3.46 | ROE 12.39% | ROCE 13.7% |
Dividend yield 0.2% | Debt/Equity ratio 0.4 | EPS 15.43 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
50%
Hold
50%
Sell
0%
This analysis is based on the reviews of 2 experts in the last 7 days
Aarti Drugs Fundamentals
Aarti Drugs Financial Ratios
Operating profit margin12.06% | Net profit margin6.26% |
ROE12.39% | ROA6.5% |
ROCE13.7% |
Learn more
Aarti Drugs Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹490.00 | ₹483.90 | -0.80% |
Fri, Nov 1 2024 | ₹484.15 | ₹487.80 | |
Thu, Oct 31 2024 | ₹484.75 | ₹484.15 | -0.11% |
Wed, Oct 30 2024 | ₹486.60 | ₹484.70 | |
Tue, Oct 29 2024 | ₹484.30 | ₹484.05 | |
Mon, Oct 28 2024 | ₹477.20 | ₹483.80 | |
Fri, Oct 25 2024 | ₹471.00 | ₹474.70 | -2.10% |
Thu, Oct 24 2024 | ₹488.95 | ₹484.90 | -0.66% |
Events
Corporate actions
Dividend • ₹1/share
Ex date 06 Feb 2024
Dividend • ₹1/share
Ex date 08 Feb 2023
Dividend • ₹1/share
Ex date 09 Feb 2022
Learn more
More